Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cirtran (CIRX) Other Accumulated Expenses (2017 - 2025)

Cirtran's Other Accumulated Expenses history spans 13 years, with the latest figure at $371822.0 for Q4 2025.

  • Quarterly results put Other Accumulated Expenses at $371822.0 for Q4 2025, down 79.96% from a year ago — trailing twelve months through Dec 2025 was $371822.0 (down 79.96% YoY), and the annual figure for FY2025 was $371822.0, down 79.96%.
  • Other Accumulated Expenses for Q4 2025 was $371822.0 at Cirtran, down from $1.8 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $2.1 million in Q3 2024 to a low of $371822.0 in Q4 2025.
  • The 5-year median for Other Accumulated Expenses is $842472.0 (2021), against an average of $1.0 million.
  • The sharpest move saw Other Accumulated Expenses surged 322.73% in 2024, then plummeted 79.96% in 2025.
  • Year by year, Other Accumulated Expenses stood at $793128.0 in 2021, then crashed by 36.92% to $500322.0 in 2022, then fell by 12.29% to $438822.0 in 2023, then surged by 322.73% to $1.9 million in 2024, then plummeted by 79.96% to $371822.0 in 2025.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $371822.0, $1.8 million, and $394822.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.